Even within the areas that GTC has carved out for itself in conjunction with its partners LEO, Merrimack, LFB, ProGenetics, PharmAthene, and maybe more to come, the risks are more with the financial stability of the company than the technology. We are supplying materials for important trials and beyond so that these players have a larger and larger stake in GTC's operations. They have got to be wondering why they placed such a large stake on GTC's integrity and now they are basically a going concern.
I think we get sold soon.